Philip Morris' Q4 Earnings on Deck: Key Factors to Understand
PM's Q4 results are likely to reflect gains from pricing and smoke-free strength amid volatile currency movements.
The American Journal of Managed Care16d
In a First-of-Its-Kind Decision, FDA Will Allow Marketing of Nicotine Pouches
This marketing decision from the FDA covers 2 nicotine strengths, 3 mg and 6 mg, and 10 flavors of the small tobacco-free synthetic pouches.
The Week8d
FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.
FDA decision makes ZYN the first authorized nicotine pouch product • Science-based decision affirms that ZYN nicotine pouches are a ...
AFP2d
FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.
The FDA’s authorization of all ZYN nicotine pouches currently marketed by Swedish Match in the U.S. is an important step to protect the public health by providing better alternatives to ...
Morningstar20d
FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.
U.S. Marketing Practices Support 21+ Access Only Swedish Match N.A. LLC is a subsidiary of Philip Morris International Inc. (PMI). PMI’s U.S. affiliates are committed to responsible marketing ...
Yahoo Finance21d
FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.
Swedish Match N.A. LLC is a subsidiary of Philip Morris International Inc. (PMI). PMI’s U.S. affiliates are committed to responsible marketing practices focused on limiting access to adults 21 ...